{"id":3,"date":"2021-01-27T16:51:35","date_gmt":"2021-01-27T16:51:35","guid":{"rendered":"https:\/\/neuraxpharm.com\/v2\/?page_id=3"},"modified":"2022-02-15T11:30:26","modified_gmt":"2022-02-15T11:30:26","slug":"ochrana-osobnych-udajov","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov","title":{"rendered":"Ochrana osobn\u00fdch \u00fadajov"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"3\" class=\"elementor elementor-3\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4267eac8 politicas elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4267eac8\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;b9bf352&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-11149c0c\" data-id=\"11149c0c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-27cfa8e elementor-widget elementor-widget-heading\" data-id=\"27cfa8e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Ochrana osobn\u00fdch \u00fadajov<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5d244c20 elementor-widget elementor-widget-text-editor\" data-id=\"5d244c20\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>V s\u00falade s nariaden\u00edm Eur\u00f3pskeho parlamentu a Rady (E\u00da) 2016\/679 z 27. apr\u00edla 2016 o ochrane fyzick\u00fdch os\u00f4b pri spracovan\u00ed osobn\u00fdch \u00fadajov a vo\u013enom pohybe t\u00fdchto \u00fadajov, ako aj s ak\u00fdmiko\u013evek in\u00fdmi platn\u00fdmi ustanoveniami o ochrane \u00fadajov, V\u00e1m t\u00fdmto poskytujeme podrobn\u00e9 inform\u00e1cie o spracovan\u00ed va\u0161ich osobn\u00fdch \u00fadajov.<\/p><p><strong>1. Kto je prev\u00e1dzkovate\u013eom \u00fadajov v s\u00favislosti so spracovan\u00edm va\u0161ich osobn\u00fdch \u00fadajov?<\/strong><\/p><table><tbody><tr><td>Prev\u00e1dzkovate\u013e \u00fadajov<\/td><td><p>Spolo\u010dnosti skupiny Neuraxpharm (\u010falej len \u201eNeuraxpharm\u201c). Kontaktn\u00e9 \u00fadaje uveden\u00fdch spolo\u010dnost\u00ed n\u00e1jdete v nasleduj\u00facom odkaze<\/p><p>[\u2026]<\/p><p>Najm\u00e4 v pr\u00edpade\u00a0Farmakovigilance bude zodpovedn\u00e1 spolo\u010dnos\u0165\u00a0CEREBRO SPAIN BIDCO S.L.<\/p><\/td><\/tr><tr><td>E-mailov\u00e1 adresa<\/td><td><a href=\"\/\">gdpr@neuraxpharm.com<\/a><\/td><\/tr><\/tbody><\/table><p><strong>2. Na ak\u00e9 \u00fa\u010dely sprac\u00favame va\u0161e osobn\u00e9 \u00fadaje?<\/strong><\/p><p>Spolo\u010dnos\u0165 Neuraxpharm sprac\u00fava osobn\u00e9 \u00fadaje, ktor\u00e9 n\u00e1m poskytnete vyplnen\u00edm kontaktn\u00fdch formul\u00e1rov, kontaktovan\u00edm na e-mailov\u00fa adresu alebo telef\u00f3nne \u010d\u00edslo uveden\u00e9 na webovej str\u00e1nke na \u00fa\u010dely uveden\u00e9 ni\u017e\u0161ie:<\/p><ol start=\"1\"><li><strong>Obchodn\u00e1 komunik\u00e1cia<\/strong><\/li><\/ol><p>V r\u00e1mci svojej propaga\u010dnej \u010dinnosti v\u00e1m Neuraxpharm m\u00f4\u017ee poskytn\u00fa\u0165 prostriedky na registr\u00e1ciu, alebo prihl\u00e1senie sa na odber noviniek, alebo s\u00favisiacich komer\u010dn\u00fdch inform\u00e1ci\u00ed. Tak\u00e9to prostriedky v\u017edy vy\u017eaduj\u00fa v\u00e1\u0161 v\u00fdslovn\u00fd s\u00fahlas, aby sme v\u00e1m mohli posiela\u0165 novinky alebo obchodn\u00e9 inform\u00e1cie. Preto, ak ste n\u00e1m dali v\u00e1\u0161 s\u00fahlas, spolo\u010dnos\u0165 Neruaxpharm v\u00e1m po\u0161le inform\u00e1cie o svojich produktoch.<\/p><p>S\u00fahlas so zasielan\u00edm obchodn\u00fdch ozn\u00e1men\u00ed m\u00f4\u017eete kedyko\u013evek odvola\u0165 kliknut\u00edm na odkaz alebo tla\u010didlo uveden\u00e9 v ka\u017edom obchodnom ozn\u00e1men\u00ed alebo zaslan\u00edm e-mailu na nasleduj\u00facu adresu <a href=\"\/\">gdpr@neuraxpharm.com<\/a>.<\/p><ol start=\"2\"><li><strong>Kontakt pre tla\u010d<\/strong><\/li><\/ol><p>Odpoveda\u0165 na \u017eiadosti o inform\u00e1cie.<\/p><ol start=\"3\"><li><strong>Kan\u00e1ly etiky a dodr\u017eiavania predpisov :<\/strong><\/li><\/ol><p>Riadi\u0165 s\u0165a\u017enosti podan\u00e9 spolo\u010dnosti Neuraxpharm prostredn\u00edctvom kan\u00e1la Etika a dodr\u017eiavanie predpisov, ako aj vykon\u00e1va\u0165 vy\u0161etrovanie ozn\u00e1men\u00fdch skuto\u010dnost\u00ed, prija\u0165 vhodn\u00e9 n\u00e1pravn\u00e9 opatrenia a v pr\u00edpade potreby informova\u0165 pou\u017e\u00edvate\u013ea o v\u00fdsledku postupu.<\/p><ol start=\"4\"><li><strong>Hl\u00e1senie ved\u013eaj\u0161\u00edch \u00fa\u010dinkov<\/strong><\/li><\/ol><ul><li>Odpoveda\u0165 na \u017eiadosti o inform\u00e1cie, ktor\u00e9 u\u017e\u00edvate\u013e podal t\u00fdmto sp\u00f4sobom.<\/li><li>Spravova\u0165 z\u00e1znam podozren\u00ed z ne\u017eiaducej reakcie na liek.<\/li><\/ul><ol style=\"margin-top: 10px; margin-bottom: 10px;\" start=\"5\"><li><strong>Kontakt so zdravotn\u00edckymi pracovn\u00edkmi<\/strong><\/li><\/ol><ol style=\"margin-top: 10px; margin-bottom: 10px;\" start=\"6\"><li><strong>Medzin\u00e1rodn\u00fd obchod<\/strong><\/li><\/ol><ol style=\"margin-top: 10px; margin-bottom: 10px;\" start=\"7\"><li><strong>Register webov\u00fdch str\u00e1nok (\u201eS\u00fakromn\u00e1 oblas\u0165\u201c)<\/strong><\/li><\/ol><p>Spravujte svoju \u017eiados\u0165 o registr\u00e1ciu na na\u0161ej webovej str\u00e1nke.<\/p><p><strong>3. Ako dlho budeme uchov\u00e1va\u0165 va\u0161e osobn\u00e9 \u00fadaje?<\/strong><\/p><p>Spolo\u010dnos\u0165 Neuraxpharm sa zav\u00e4zuje sprac\u00fava\u0165 va\u0161e osobn\u00e9 \u00fadaje tak dlho, ako je to u\u017eito\u010dn\u00e9 a potrebn\u00e9 na to, aby v\u00e1m mohla pon\u00faknu\u0165 kvalitn\u00e9 slu\u017eby. Preto spolo\u010dnos\u0165 Neuraxpharm vynalo\u017e\u00ed v\u0161etko primeran\u00e9 a primeran\u00e9 \u00fasilie na minimaliz\u00e1ciu \u010dasu potrebn\u00e9ho na spracovanie a ulo\u017eenie va\u0161ich osobn\u00fdch \u00fadajov.<\/p><p>Radi by sme v\u00e1s informovali najm\u00e4 o tom, \u017ee va\u0161e osobn\u00e9 \u00fadaje sa bud\u00fa uchov\u00e1va\u0165 s pou\u017eit\u00edm potrebn\u00fdch technick\u00fdch a organiza\u010dn\u00fdch opatren\u00ed na zaru\u010denie bezpe\u010dnosti a integrity \u00fadajov po\u010das nasleduj\u00facich obdob\u00ed a v ka\u017edom pr\u00edpade tak dlho, k\u00fdm nepo\u017eiadate o ich vymazanie:<\/p><table><tbody><tr><td><strong>\u00da\u010del<\/strong><\/td><td><strong>Obdobie skladovania<\/strong><\/td><\/tr><tr><td>Obchodn\u00e9 ozn\u00e1menia (oddiel 2.i)<\/td><td>K\u00fdm nezru\u0161\u00edte svoj s\u00fahlas so spracovan\u00edm.<\/td><\/tr><tr><td>Tla\u010dov\u00fd kontakt (oddiel 2.ii)<\/td><td>Pokia\u013e s\u00fa potrebn\u00e9 na splnenie va\u0161ej po\u017eiadavky.<\/td><\/tr><tr><td>Kan\u00e1ly etiky a dodr\u017eiavania predpisov (oddiel 2.iii)<\/td><td>Pokia\u013e je potrebn\u00e9 rozhodn\u00fa\u0165 o vhodnosti za\u010datia vy\u0161etrovania nahl\u00e1sen\u00fdch udalost\u00ed a ak je to vhodn\u00e9, na \u010das potrebn\u00fd na vyrie\u0161enie s\u0165a\u017enosti.<\/td><\/tr><tr><td>Spr\u00e1va o ved\u013eaj\u0161\u00edch \u00fa\u010dinkoch (oddiel 2.iv)<\/td><td>Tie, ktor\u00e9 sa predpokladaj\u00fa v pr\u00e1vnych predpisoch upravuj\u00facich ochranu pr\u00e1va na zdravie a informovanie a vzdel\u00e1vanie spotrebite\u013eov verejn\u00fdmi pr\u00e1vomocami, pokia\u013e ide o preml\u010danie zodpovednosti.<\/td><\/tr><tr><td><p>Kontakt so zdravotn\u00edckymi pracovn\u00edkmi (\u010das\u0165 2.v)<\/p><p>\u00a0<\/p><\/td><td>\u00a0<\/td><\/tr><tr><td>Obchod v medzin\u00e1rodnom obchode (oddiel 2.vi)<\/td><td>\u00a0<\/td><\/tr><tr><td>Register webov\u00fdch str\u00e1nok (oddiel 2.vii)<\/td><td>\u00a0<\/td><\/tr><\/tbody><\/table><p>V ka\u017edom pr\u00edpade, aj ke\u010f po\u017eiadate o vymazanie svojich osobn\u00fdch \u00fadajov, spolo\u010dnos\u0165 Neuraxpharm je opr\u00e1vnen\u00e1 ich uchov\u00e1va\u0165 a uchov\u00e1va\u0165 pod pr\u00edslu\u0161n\u00fdm blokovan\u00edm po dobu potrebn\u00fa na splnenie pr\u00edslu\u0161n\u00fdch pr\u00e1vnych povinnost\u00ed, ako aj na ich spr\u00edstupnenie pr\u00edslu\u0161n\u00fdm org\u00e1nom v r\u00f4znych z\u00e1le\u017eitostiach, ktor\u00e9 sa na ne vz\u0165ahuj\u00fa.<\/p><p><strong>4. Ak\u00fd je pr\u00e1vny z\u00e1klad pre spracovanie va\u0161ich osobn\u00fdch \u00fadajov?<\/strong><\/p><p>Pr\u00e1vny z\u00e1klad sprac\u00favania va\u0161ich osobn\u00fdch \u00fadajov sa l\u00ed\u0161i v z\u00e1vislosti od \u00fa\u010delu sprac\u00favania v s\u00falade s odsekom 2 t\u00fdchto z\u00e1sad:<\/p><table><tbody><tr><td><strong>\u00a0<\/strong><\/td><td><strong>Pr\u00e1vny z\u00e1klad<\/strong><\/td><\/tr><tr><td>\u00a0<\/td><td>V\u00e1\u0161 s\u00fahlas.<\/td><\/tr><tr><td>\u00a0<\/td><td>V\u00e1\u0161 s\u00fahlas poskytnut\u00fd pri kontaktovan\u00ed prostredn\u00edctvom kontaktn\u00e9ho formul\u00e1ra.<\/td><\/tr><tr><td>\u00a0<\/td><td>Pr\u00e1vna povinnos\u0165, najm\u00e4 v s\u00favislosti so smernicou (E\u00da) 2019\/1937 o ochrane jednotlivcov, ktor\u00ed ohlasuj\u00fa poru\u0161enia pr\u00e1va Eur\u00f3pskej \u00fanie.<\/td><\/tr><tr><td>\u00a0<\/td><td>Pr\u00e1vna povinnos\u0165, najm\u00e4 NARIADEN\u00cdM Eur\u00f3pskeho parlamentu a Rady (E\u00da) \u010d. 1235\/2010 z 15. decembra 2010, ktor\u00fdm sa men\u00ed a dop\u013a\u0148a, pokia\u013e ide o farmakovigilanciu liekov na hum\u00e1nne pou\u017eitie, nariadenie (ES) \u010d. 726\/2004, ktor\u00fdm sa stanovuj\u00fa postupy Spolo\u010denstva pri povo\u013eovan\u00ed liekov na hum\u00e1nne pou\u017eitie a na veterin\u00e1rne pou\u017eitie a pri vykon\u00e1van\u00ed dozoru nad t\u00fdmito liekmi a ktor\u00fdm sa zria\u010fuje Eur\u00f3pska agent\u00fara pre lieky, a nariadenie (ES) \u010d. 1394\/2007 o liekoch na inovat\u00edvnu lie\u010dbu.<\/td><\/tr><\/tbody><\/table><p><strong>5. Komu spr\u00edstupn\u00edme va\u0161e osobn\u00e9 \u00fadaje?<\/strong><\/p><p>Va\u0161e osobn\u00e9 \u00fadaje nebud\u00fa poskytnut\u00e9 tret\u00edm stran\u00e1m, s v\u00fdnimkou dod\u00e1vate\u013eov, ktor\u00ed n\u00e1m poskytuj\u00fa slu\u017eby pre spr\u00e1vne poskytovanie slu\u017eieb, ktor\u00e9 poskytujeme. Spolo\u010dnos\u0165 Neuraxpharm m\u00f4\u017ee tie\u017e poskytn\u00fa\u0165 va\u0161e osobn\u00e9 \u00fadaje verejn\u00fdm org\u00e1nom a \u00faradom (administrat\u00edvnym alebo s\u00fadnym) v pr\u00edpadoch, ke\u010f sa uplat\u0148uje z\u00e1konn\u00e1 povinnos\u0165.<\/p><p>Informujeme v\u00e1s, \u017ee \u00fadaje, ktor\u00e9 ste n\u00e1m poskytli, m\u00f4\u017eu by\u0165 poskytnut\u00e9 skupine spolo\u010dnost\u00ed, ktor\u00e9 s\u00fa s\u00fa\u010das\u0165ou skupiny Neuraxpharm, na intern\u00e9 administrat\u00edvne \u00fa\u010dely.<\/p><p><strong>6. Ak\u00e9 s\u00fa va\u0161e pr\u00e1va t\u00fdkaj\u00face sa va\u0161ich osobn\u00fdch \u00fadajov a ako ich m\u00f4\u017eete uplatni\u0165?<\/strong><\/p><p>Kedyko\u013evek m\u00e1te pr\u00e1vo na pr\u00edstup k svojim osobn\u00fdm \u00fadajom, ako aj pr\u00e1vo po\u017eiada\u0165 o opravu nepresn\u00fdch \u00fadajov alebo pr\u00edpadne po\u017eiada\u0165 o ich vymazanie, ak okrem in\u00fdch d\u00f4vodov u\u017e \u00fadaje nie s\u00fa potrebn\u00e9 na \u00fa\u010dely, na ktor\u00e9 boli zhroma\u017eden\u00e9.<\/p><p>Za ur\u010dit\u00fdch okolnost\u00ed m\u00f4\u017eete po\u017eiada\u0165, aby sme obmedzili spracovanie va\u0161ich \u00fadajov, v takom pr\u00edpade si ich ponech\u00e1me len na uplatnenie alebo obhajobu n\u00e1rokov.<\/p><p>Za ur\u010dit\u00fdch okolnost\u00ed a z d\u00f4vodov s\u00favisiacich s va\u0161ou konkr\u00e9tnou situ\u00e1ciou m\u00f4\u017eete namieta\u0165 proti spracovaniu va\u0161ich \u00fadajov. Spolo\u010dnos\u0165 Neuraxpharm prestane sprac\u00fava\u0165 \u00fadaje, s v\u00fdnimkou z\u00e1va\u017en\u00fdch legit\u00edmnych d\u00f4vodov alebo uplatnenia alebo obhajoby ak\u00fdchko\u013evek n\u00e1rokov.<\/p><p>M\u00f4\u017eete tie\u017e uplatni\u0165 svoje pr\u00e1vo na prenosnos\u0165 va\u0161ich \u00fadajov a kedyko\u013evek odvola\u0165 svoj s\u00fahlas bez toho, aby to ovplyvnilo z\u00e1konnos\u0165 spracovania na z\u00e1klade v\u00e1\u0161ho s\u00fahlasu pred jeho odvolan\u00edm.<\/p><p>Ak si prajete uplatni\u0165 niektor\u00e9 zo svojich pr\u00e1v, m\u00f4\u017eete n\u00e1s kontaktova\u0165 zaslan\u00edm listu, prilo\u017een\u00edm dokumentu preukazuj\u00faceho va\u0161u toto\u017enos\u0165 a v\u00fdslovn\u00fdm uveden\u00edm pr\u00e1va, ktor\u00e9 chcete uplatni\u0165, na vy\u0161\u0161ie uvedenej adrese alebo zaslan\u00edm e-mailu na adresu <a href=\"mailto:gdpr@neuraxpharm.com\">gdpr@neuraxpharm.com<\/a>.<\/p><p>Nakoniec v\u00e1s informujeme, \u017ee sa m\u00f4\u017eete obr\u00e1ti\u0165 na pr\u00edslu\u0161n\u00fd org\u00e1n na ochranu \u00fadajov vo va\u0161ej krajine a in\u00e9 pr\u00edslu\u0161n\u00e9 verejn\u00e9 org\u00e1ny v pr\u00edpade ak\u00e9hoko\u013evek n\u00e1roku vypl\u00fdvaj\u00faceho zo spracovania va\u0161ich osobn\u00fdch \u00fadajov.<\/p><p><strong>7. D\u00f4vernos\u0165 a bezpe\u010dnostn\u00e9 opatrenia<\/strong><\/p><p>Neuraxpharm zaviedol v\u0161etky primeran\u00e9 bezpe\u010dnostn\u00e9 opatrenia, aby zabezpe\u010dil, \u017ee ned\u00f4jde k strate, zmene, zneu\u017eitiu alebo neopr\u00e1vnen\u00e9mu pr\u00edstupu k sprac\u00favan\u00fdm osobn\u00fdm \u00fadajom. Neuraxpharm pravidelne sk\u00fama bezpe\u010dnostn\u00e9 opatrenia, ktor\u00e9 sa uplat\u0148uj\u00fa na zabezpe\u010denie toho, aby boli v\u017edy vhodn\u00e9 vo vz\u0165ahu k spracovaniu, ktor\u00e9 vykon\u00e1va.<\/p><p>Bez oh\u013eadu na vy\u0161\u0161ie uveden\u00e9, pou\u017e\u00edvanie internetu nie je \u00faplne bezpe\u010dn\u00e9 a nem\u00f4\u017eeme zaru\u010di\u0165 bezpe\u010dnos\u0165 va\u0161ich inform\u00e1ci\u00ed.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Ochrana osobn\u00fdch \u00fadajov V s\u00falade s nariaden\u00edm Eur\u00f3pskeho parlamentu a Rady (E\u00da) 2016\/679 z 27. apr\u00edla 2016 o ochrane fyzick\u00fdch os\u00f4b pri spracovan\u00ed osobn\u00fdch \u00fadajov a vo\u013enom pohybe t\u00fdchto \u00fadajov, ako aj s ak\u00fdmiko\u013evek in\u00fdmi platn\u00fdmi ustanoveniami o ochrane \u00fadajov, V\u00e1m t\u00fdmto poskytujeme podrobn\u00e9 inform\u00e1cie o spracovan\u00ed va\u0161ich osobn\u00fdch \u00fadajov. 1. Kto je prev\u00e1dzkovate\u013eom \u00fadajov [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-3","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Ochrana osobn\u00fdch \u00fadajov - Neuraxpharm SK<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ochrana osobn\u00fdch \u00fadajov\" \/>\n<meta property=\"og:description\" content=\"Ochrana osobn\u00fdch \u00fadajov V s\u00falade s nariaden\u00edm Eur\u00f3pskeho parlamentu a Rady (E\u00da) 2016\/679 z 27. apr\u00edla 2016 o ochrane fyzick\u00fdch os\u00f4b pri spracovan\u00ed osobn\u00fdch \u00fadajov a vo\u013enom pohybe t\u00fdchto \u00fadajov, ako aj s ak\u00fdmiko\u013evek in\u00fdmi platn\u00fdmi ustanoveniami o ochrane \u00fadajov, V\u00e1m t\u00fdmto poskytujeme podrobn\u00e9 inform\u00e1cie o spracovan\u00ed va\u0161ich osobn\u00fdch \u00fadajov. 1. Kto je prev\u00e1dzkovate\u013eom \u00fadajov [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm SK\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-15T11:30:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 min\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov\",\"url\":\"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov\",\"name\":\"Ochrana osobn\u00fdch \u00fadajov - Neuraxpharm SK\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/#website\"},\"datePublished\":\"2021-01-27T16:51:35+00:00\",\"dateModified\":\"2022-02-15T11:30:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.neuraxpharm.com\/sk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ochrana osobn\u00fdch \u00fadajov\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/sk\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/sk\/\",\"name\":\"Neuraxpharm SK\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/sk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ochrana osobn\u00fdch \u00fadajov - Neuraxpharm SK","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov","og_locale":"sk_SK","og_type":"article","og_title":"Ochrana osobn\u00fdch \u00fadajov","og_description":"Ochrana osobn\u00fdch \u00fadajov V s\u00falade s nariaden\u00edm Eur\u00f3pskeho parlamentu a Rady (E\u00da) 2016\/679 z 27. apr\u00edla 2016 o ochrane fyzick\u00fdch os\u00f4b pri spracovan\u00ed osobn\u00fdch \u00fadajov a vo\u013enom pohybe t\u00fdchto \u00fadajov, ako aj s ak\u00fdmiko\u013evek in\u00fdmi platn\u00fdmi ustanoveniami o ochrane \u00fadajov, V\u00e1m t\u00fdmto poskytujeme podrobn\u00e9 inform\u00e1cie o spracovan\u00ed va\u0161ich osobn\u00fdch \u00fadajov. 1. Kto je prev\u00e1dzkovate\u013eom \u00fadajov [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov","og_site_name":"Neuraxpharm SK","article_modified_time":"2022-02-15T11:30:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Predpokladan\u00fd \u010das \u010d\u00edtania":"6 min\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov","url":"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov","name":"Ochrana osobn\u00fdch \u00fadajov - Neuraxpharm SK","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/sk\/#website"},"datePublished":"2021-01-27T16:51:35+00:00","dateModified":"2022-02-15T11:30:26+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/sk\/ochrana-osobnych-udajov#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neuraxpharm.com\/sk\/"},{"@type":"ListItem","position":2,"name":"Ochrana osobn\u00fdch \u00fadajov"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/sk\/#website","url":"https:\/\/www.neuraxpharm.com\/sk\/","name":"Neuraxpharm SK","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/sk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages\/3","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/comments?post=3"}],"version-history":[{"count":132,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages\/3\/revisions"}],"predecessor-version":[{"id":24769,"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/pages\/3\/revisions\/24769"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/sk\/wp-json\/wp\/v2\/media?parent=3"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}